ARTICLE | Clinical News
Natesto regulatory update
April 14, 2017 4:32 PM UTC
Hyundai submitted an NDA to South Korea’s Ministry of Food and Drug Safety (MFDS) for Natesto to treat low testosterone. Hyundai has exclusive, South Korean rights to the bioadhesive intranasal gel fo...